Clinical Application of a Tissue-Cultured Skin Autograft: An Alternative for the Treatment of Non-Healing or Slowly Healing Wounds?Zöller N.a · Valesky E.a · Butting M.a · Hofmann M.a · Kippenberger S.a · Bereiter-Hahn J.b · Bernd A.a · Kaufmann R.a
aDepartment of Dermatology, Venereology and Allergology, Goethe University Medical School, and bKinematic Cell Research Group, Goethe University, Frankfurt/Main, Germany
Do you have an account?
- Rent for 48h to view
- Buy Cloud Access for unlimited viewing via different devices
- Synchronizing in the ReadCube Cloud
- Printing and saving restrictions apply
Rental: USD 8.50
Cloud: USD 20.00
Article / Publication Details
Background: The treatment regime of non-healing or slowly healing wounds is constantly improving. One aspect is surgical defect coverage whereby mesh grafts and keratinocyte suspension are applied. Objective: Tissue-cultured skin autografts may be an alternative for the treatment of full-thickness wounds and wounds that cover large areas of the body surface. Methods: Autologous epidermal and dermal cells were isolated, expanded in vitro and seeded on collagen-elastin scaffolds. The developed autograft was immunohistochemically characterized and subsequently transplanted onto a facial chronic ulceration of a 71-year-old patient with vulnerable atrophic skin. Results: Characterization of the skin equivalent revealed comparability to healthy human skin due to the epidermal strata, differentiation and proliferation markers. Within 138 days, the skin structure at the transplantation site closely correlated with the adjacent undisturbed skin. Conclusion: The present study demonstrates the comparability of the developed organotypic skin equivalent to healthy human skin and the versatility for clinical applications.
© 2014 S. Karger AG, Basel
- Jones JE, Nelson EA, Al-Hity A: Skin grafting for venous leg ulcers. Cochrane Database Syst Rev 2013;1:CD001737.
- Poskitt KR, James AH, Lloyd-Davies ER, Walton J, McCollum C: Pinch skin grafting or porcine dermis in venous ulcers: a randomised clinical trial. Br Med J (Clin Res Ed) 1987;294:674-676.
- Sibbald RG, Zuker R, Coutts P, Coelho S, Williamson D, Queen D: Using a dermal skin substitute in the treatment of chronic wounds secondary to recessive dystrophic epidermolysis bullosa: a case series. Ostomy Wound Manage 2005;51:22-46.
- Centanni JM, Straseski JA, Wicks A, Hank JA, Rasmussen CA, Lokuta MA, Schurr MJ, Foster KN, Faucher LD, Caruso DM, Comer AR, Allen-Hoffmann BL: StrataGraft skin substitute is well-tolerated and is not acutely immunogenic in patients with traumatic wounds: results from a prospective, randomized, controlled dose escalation trial. Ann Surg 2011;253:672-683.
- Schurr MJ, Foster KN, Centanni JM, Comer AR, Wicks A, Gibson AL, Thomas-Virnig CL, Schlosser SJ, Faucher LD, Lokuta MA, Allen-Hoffmann BL: Phase I/II clinical evaluation of StrataGraft: a consistent, pathogen-free human skin substitute. J Trauma 2009;66:866-873.
- Hollander D, Stein M, Bernd A, Windolf J, Pannike A: Autologous keratinocytes cultured on benzylester hyaluronic acid membranes in the treatment of chronic full-thickness ulcers. J Wound Care 1999;8:351-355.
- Boyce ST, Hansbrough JF: Biologic attachment, growth, and differentiation of cultured human epidermal keratinocytes on a graftable collagen and chondroitin-6-sulfate substrate. Surgery 1988;103:421-431.
- Cuono C, Langdon R, McGuire J: Use of cultured epidermal autografts and dermal allografts as skin replacement after burn injury. Lancet 1986;1:1123-1124.
- Mensik I, Lamme EN, Riesle J, Brychta P: Effectiveness and safety of the PEGT/PBT copolymer scaffold as dermal substitute in scar reconstruction wounds (feasibility trial). Cell Tissue Bank 2002;3:245-253.
- Rheinwald JG, Green H: Serial cultivation of strains of human epidermal keratinocytes: the formation of keratinizing colonies from single cells. Cell 1975;6:331-343.
- Kuroyanagi Y, Kubo K, Matsui H, Kim HJ, Numari S, Mabuchi Y, Kagawa S: Establishment of banking system for allogeneic cultured dermal substitute. Artif Organs 2004;28:13-21.
- Kondo S, Kooshesh F, Sauder DN: Penetration of keratinocyte-derived cytokines into basement membrane. J Cell Physiol 1997;171:190-195.
- Gillitzer R, Goebeler M: Chemokines in cutaneous wound healing. J Leukoc Biol 2001;69:513-521.
- Horch RE, Kopp J, Kneser U, Beier J, Bach AD: Tissue engineering of cultured skin substitutes. J Cell Mol Med 2005;9:592-608.
- El Ghalbzouri A, Jonkman MF, Dijkman R, Ponec M: Basement membrane reconstruction in human skin equivalents is regulated by fibroblasts and/or exogenously activated keratinocytes. J Invest Dermatol 2005;124:79-86.
- El-Ghalbzouri A, Lamme EN, van Blitterswijk C, Koopman J, Ponec M: The use of PEGT/PBT as a dermal scaffold for skin tissue engineering. Biomaterials 2004;25:2987-2996.
- Schlotmann K, Kaeten M, Black AF, Damour O, Waldmann-Laue M, Forster T: Cosmetic efficacy claims in vitro using a three-dimensional human skin model. Int J Cosmet Sci 2001;23:309-318.
- Kreis RW, Mackie DP, Hermans RR, Vloemans AR: Expansion techniques for skin grafts: comparison between mesh and Meek island (sandwich-) grafts. Burns 1994;20 (suppl 1):S39-S42.
- Phillips LG, Robson MC, Smith DJ, Phillips WA, Gracia WD, McHugh TP, Sullivan WG, Mathoney K, Swartz K, Meltzer T: Uses and abuses of a biosynthetic dressing for partial skin thickness burns. Burns 1989;15:254-256.
- Uhlig C, Rapp M, Dittel KK: New strategies for the treatment of thermally injured hands with regard to the epithelial substitute Suprathel (in German). Handchir Mikrochir Plast Chir 2007;39:314-319.
- Schoepe S, Schaecke H, Bernd A, Zoeller N, Asadullah K: Identification of novel in vitro test systems for the determination of glucocorticoid receptor ligand-induced skin atrophy. Skin Pharmacol Physiol 2010;23:139-151.
- Zoller NN, Kippenberger S, Thaci D, Mewes K, Spiegel M, Sattler A, Schultz M, Bereiter-Hahn J, Kaufmann R, Bernd A: Evaluation of beneficial and adverse effects of glucocorticoids on a newly developed full-thickness skin model. Toxicol In Vitro 2008;22:747-759.
- Mewes KR, Raus M, Bernd A, Zoller NN, Sattler A, Graf R: Elastin expression in a newly developed full-thickness skin equivalent. Skin Pharmacol Physiol 2007;20:85-95.
- Hofmann M, Guschel M, Bernd A, Bereiter-Hahn J, Kaufmann R, Tandi C, Wiig H, Kippenberger S: Lowering of tumor interstitial fluid pressure reduces tumor cell proliferation in a xenograft tumor model. Neoplasia 2006;8:89-95.
- Ryssel H, Gazyakan E, Germann G, Ohlbauer M: The use of MatriDerm in early excision and simultaneous autologous skin grafting in burns - a pilot study. Burns 2008;34:93-97.
- Cario-Andre M, Briganti S, Picardo M, Nikaido O, Gall Y, Ginestar J, Taieb A: Epidermal reconstructs: a new tool to study topical and systemic photoprotective molecules. J Photochem Photobiol B 2002;68:79-87.
- Curren RD, Mun GC, Gibson DP, Aardema MJ: Development of a method for assessing micronucleus induction in a 3D human skin model (EpiDerm). Mutat Res 2006;607:192-204.
- Roguet R, Cohen C, Leclaire J, Tessonneaud E, Gagne C, Teissier MH: Use of a standardized reconstructed epidermis kit to assess in vitro the tolerance and the efficacy of cosmetics. Int J Cosmet Sci 2000;22:409-419.
- Kaufmann R, Greiner D, Kippenberger S, Bernd A: Grafting of in vitro cultured melanocytes onto laser-ablated lesions in vitiligo. Acta Derm Venereol 1998;78:136-138.
- Gibbs S, van den Hoogenband HM, Kirtschig G, Richters CD, Spiekstra SW, Breetveld M, Scheper RJ, de Boer EM: Autologous full-thickness skin substitute for healing chronic wounds. Br J Dermatol 2006;155:267-274.
- Wang Z, Wang Y, Farhangfar F, Zimmer M, Zhang Y: Enhanced keratinocyte proliferation and migration in co-culture with fibroblasts. PLoS One 2012;7:e40951.
- Jubin K, Martin Y, Lawrence-Watt DJ, Sharpe JR: A fully autologous co-culture system utilising non-irradiated autologous fibroblasts to support the expansion of human keratinocytes for clinical use. Cytotechnology 2011;63:655-662.
- Kielty CM, Sherratt MJ, Shuttleworth CA: Elastic fibres. J Cell Sci 2002;115:2817-2828.
- Kurzen H, Henrich C, Booken D, Poenitz N, Gratchev A, Klemke CD, Engstner M, Goerdt S, Maas-Szabowski N: Functional characterization of the epidermal cholinergic system in vitro. J Invest Dermatol 2006;126:2458-2472.
- Lee JH, An HT, Chung JH, Kim KH, Eun HC, Cho KH: Acute effects of UVB radiation on the proliferation and differentiation of keratinocytes. Photodermatol Photoimmunol Photomed 2002;18:253-261.
- Onuma H, Mastui C, Morohashi M: Quantitative analysis of the proliferation of epidermal cells using a human skin organ culture system and the effect of DbcAMP using markers of proliferation (BrdU, Ki-67, PCNA). Arch Dermatol Res 2001;293:133-138.
- Van der Vleuten CJ, Kroot EJ, de Jong EM, van de Kerkhof PC: The immunohistochemical effects of a single challenge with an intermediate dose of ultraviolet B on normal human skin. Arch Dermatol Res 1996;288:510-516.
- Edward M, Quinn JA, Sands W: Keratinocytes stimulate fibroblast hyaluronan synthesis through the release of stratifin: a possible role in the suppression of scar tissue formation. Wound Repair Regen 2011;19:379-386.
- Fujimori Y, Ueda K, Fumimoto H, Kubo K, Kuroyanagi Y: Skin regeneration for children with burn scar contracture using autologous cultured dermal substitutes and superthin auto-skin grafts: preliminary clinical study. Ann Plast Surg 2006;57:408-414.
- Harrison CA, Gossiel F, Bullock AJ, Sun T, Blumsohn A, Mac NS: Investigation of keratinocyte regulation of collagen I synthesis by dermal fibroblasts in a simple in vitro model. Br J Dermatol 2006;154:401-410.
- Harrison CA, Dalley AJ, Mac NS: A simple in vitro model for investigating epithelial/mesenchymal interactions: keratinocyte inhibition of fibroblast proliferation and fibronectin synthesis. Wound Repair Regen 2005;13:543-550.
- Jewell L, Guerrero R, Quesada AR, Chan LS, Garner WL: Rate of healing in skin-grafted burn wounds. Plast Reconstr Surg 2007;120:451-456.
Article / Publication Details
Copyright / Drug Dosage / DisclaimerCopyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.